arrow
U

Upkar S. Gill

Queen Mary University of London
H指数:31
被引数:5,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe

从目标到现实世界影响:欧洲慢性乙型肝炎和丙型肝炎护理模型的综述

2026-05-250
OAAI
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines

扩增的适应性NKG2C+ NK细胞对HBV感染的肝癌细胞系表现出强大的ADCC和功能反应。

2025-10-250
OAAI
Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes

细针抽吸物表征肝细胞癌免疫微环境以预测免疫检查点抑制剂结局

2025-10-160
OAAI
Corrigendum to “Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response” [J Hepatol (2025) 101382]

勘误:针对“Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response” [J Hepatol (2025) 101382]

2025-08-220
OAAI
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases

快速全血免疫谱分析揭示了与临床疾病分期无关的异质性HBV特异性T细胞反应模式

2025-06-210
OAAI
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses
2024-04-301
PRE
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure

乙型肝炎病毒DNA整合是乙型肝炎病毒介导的致病特性的新型生物标志物,也是当前乙型肝炎病毒治愈策略的障碍

2022-09-0220
OAAI
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
2021-09-293
OAAI